0000950170-23-063124.txt : 20231113
0000950170-23-063124.hdr.sgml : 20231113
20231113171705
ACCESSION NUMBER: 0000950170-23-063124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231110
FILED AS OF DATE: 20231113
DATE AS OF CHANGE: 20231113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harmon Seth
CENTRAL INDEX KEY: 0001993300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36483
FILM NUMBER: 231400071
MAIL ADDRESS:
STREET 1: C/O VIRIDIAN THERAPEUTICS, INC.
STREET 2: 221 CRESCENT STREET, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viridian Therapeutics, Inc.\DE
CENTRAL INDEX KEY: 0001590750
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 471187261
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BLDG. 17, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 617.272.4600
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BLDG. 17, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20170213
FORMER COMPANY:
FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20170213
FORMER COMPANY:
FORMER CONFORMED NAME: SIGNAL GENETICS, INC.
DATE OF NAME CHANGE: 20140710
4
1
ownership.xml
4
X0508
4
2023-11-10
0001590750
Viridian Therapeutics, Inc.\DE
VRDN
0001993300
Harmon Seth
C/O VIRIDIAN THERAPEUTICS, INC.
221 CRESCENT STREET, SUITE 401
WALTHAM
MA
02453
false
true
false
false
See Remarks
false
Stock Option (Right to Buy)
13.76
2023-11-10
4
A
false
270000
0
A
2033-11-10
Common Stock
270000
270000
D
The option vests in equal monthly installments through November 10, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.
Senior Vice President of Finance
/s/ Seth Harmon
2023-11-13